This is a consolidated group created after the incorporation of the Head of Group (Dr Javier Carbone) as Head of the Immunology Service at the HUPHM in August 2022. It is a multidisciplinary group that includes individuals with degrees in Medicine, Biology, Biochemistry, Chemistry, Pharmacy and Nursing as well as Laboratory Technicians.

The group leads internationally the evaluation of several immune biomarkers and immunotherapies in the field of primary and secondary immunodeficiencies. It also focuses on translational research with a special focus on solid organ transplantation, reproductive immunology, and autoimmune diseases.

Since the appointment of the Group Head to HUPHM, several national and international multicenter trials of immunotherapy and observational multicenter studies have been attracted to the Immunology Service. Competitive funding from the FIS, the Madrid Mutual Society, and also personnel contracts such as Juan Rodés, the Intramural Intensification of IDIPHISA, and the Youth Guarantee Laboratory Technicians of the CAM have been obtained. These include multicenter studies of immune biomarkers in anti-CMV immunotherapy.

The group has created the necessary logistics to be competitive and to host and manage clinical immunotherapy trials from the Immunology Service, thanks to the opening in 2022 of the Clinical Immunology Outpatient Clinic, which is rapidly becoming a Reference Clinic in the Hospital Area for the care of various immune-based diseases.

The group also projects its research carried out at the Autonomous University of Madrid through doctoral theses, master's degree projects, and undergraduate degree projects.